CancerNCT06074445
Caring for the Sexual Health and Wellbeing of Cancer Survivors and Their Intimate Partners: An Anonymous Survey
An observational study of Cancer, run by Bournemouth University at 1 site in United Kingdom.
Trial summary
The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cancer
- How many people
- 169 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 23 Aug 2022to 30 Sep 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: People with cancer or the partners of people with cancer
Who may be able to join
- Cancer survivors diagnosed with any type of cancer at age 18 years or over
- A partner of someone diagnosed with any type of cancer at age 18 years or over
- Cancer diagnosis must be no more than 10 years ago
- Cancer survivors or their partners who experienced treatment and follow up care in the United Kingdom
Who cannot join
- Cancer survivors who were diagnosed with cancer below the age of 18 years
- Partners of cancer survivors who were diagnosed with cancer below the age of 18 years
- Cancer diagnosis was more than 10 years ago
- Cancer survivors/partners of survivors where the cancer treatment and follow up was not in the United Kingdom
- Previous completion of the survey
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Bournemouth University
Bournemouth, Dorset, BH8 8AJ
About this study
Official title: An Anonymous Survey Investigating Care for the Sexual Health of Cancer Survivors and Their Intimate Partners, as Provided by the United Kingdom Hospital Cancer Team
The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. This information will be analysed and used to inform the questions asked in a separate, subsequent, qualitative study.
- Conditions
- Cancer
- Being tested
- No intervention
- Keywords
- Cancer Survivors, Neoplasms, Oncology, Sexual Health, Sexual Dysfunction, physiological, Sexual Dysfunctions, psychological, Sexuality, Barrier, Facilitator, Professional-Patient Relations, Communication
- Medical subject headings
- Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological, Sexuality, Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
No intervention
| Study group | Role | What they receive |
|---|---|---|
| People with Cancer | No intervention Receives: Other: No intervention | |
| Partners of People with Cancer | No intervention Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care
Sexual health discussion:19 examples of the sort of topics that may have been discussed in relation to sexual health
Measured: Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)
Secondary outcomes (4)
Number of participants with specific levels of impact on their sex lives by cancer and its treatments
As above
Measured: From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey
Survey questionnaire to measure the nature and prevalence of care for sexual health that cancer survivors and their intimate partners self-report experiencing from the UK hospital cancer team.
An online survey questionnaire (no validated questionnaire available and therefore research created the questionnaire based on a literature reviews on sexual health in oncology
Measured: Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)
Survey questionnaire to measure the nature and prevalence of the perceived barriers to and facilitators for care for sexual health as received by cancer survivors and their intimate partners when provided by the UK hospital cancer team.
As above
Measured: Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)
Survey questionnaire to measure to what extent groups of cancer survivors and their intimate partners with differing characteristics receive differing care for their sexual health from the UK hospital cancer team.
Participants' responses from outcomes 1-4 will be used toinform this outcome
Measured: Participants diagnosed with cancer in the previous 10 years.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Oct 2023
- Study start23 Aug 2022
- Primary completion30 Sep 2022
- Study completion30 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 169 participants (actual)
Sponsor and investigators
- Lead sponsor
- Bournemouth University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute for Health Research, Applied Research Collaboration, Wessex, Fortuneswell Cancer Trust, Dorset County Hospital NHS Foundation Trust
- Responsible party
- Sponsor
- Investigators
- Sam Porter, PhD, RN, Principal investigator, Bournemouth University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06074445
- Sponsor's protocol ID
- Ethics ID 39453
- Status last verified
- Oct 2023
- First submitted
- 3 Aug 2023
- Last updated
- 10 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Participant information sheet stated that information would not be made publicly available via a data sharing repository. This approach was taken due to the sensitive nature of the topic and was anticipated to provide reassurance and potentially improve recruitment.
Publications
Sheppard S, Culliford D, Glen T, Lee S, Sheppard ZA, Porter S. Care for sexual health in oncology survey: a regression analysis of variables associated with the likelihood of people with cancer having a sexual health discussion with the hospital cancer team. Eur J Oncol Nurs. 2025 Oct;78:102977. doi: 10.1016/j.ejon.2025.102977. Epub 2025 Sep 1.
PubMed 40967121
Study at a glance
From the registry record, last updated by the sponsor on 10 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Anonymous Survey Investigating Care for the Sexual Health of Cancer Survivors and Their Intimate Partners, as Provided by the United Kingdom Hospital Cancer Team
- ClinicalTrials.gov ID
- NCT06074445
- Acronym / sponsor ID
- Ethics ID 39453
- Conditions
- Cancer
- Keywords
- Cancer Survivors, Neoplasms, Oncology, Sexual Health, Sexual Dysfunction, physiological, Sexual Dysfunctions, psychological, Sexuality, Barrier
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 169 participants (actual)
- Lead sponsor
- Bournemouth UniversityUniversity, hospital or other
- Collaborators
- National Institute for Health Research, Applied Research Collaboration, Wessex, Fortuneswell Cancer Trust, Dorset County Hospital NHS Foundation Trust
- Study start
- 23 Aug 2022 (actual)
- Primary completion
- 30 Sep 2022 (actual)
- Study completion
- 30 Sep 2022 (actual)
- First posted
- 10 Oct 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this survey study is to provide broad information as reported by cancer survivors and their intimate partners about both their sexual health and their experiences of care from the United Kingdom hospital cancer team, including their perspectives on factors that may hinder or help care. This information will be analysed and used to inform the questions asked in a separate, subsequent, qualitative study.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| People with Cancer | – | Other: No interventionNo intervention |
| Partners of People with Cancer | – | Other: No interventionNo intervention |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- People with cancer or the partners of people with cancer
Key inclusion criteria (4 listed)
- Cancer survivors diagnosed with any type of cancer at age 18 years or over
- A partner of someone diagnosed with any type of cancer at age 18 years or over
- Cancer diagnosis must be no more than 10 years ago
- Cancer survivors or their partners who experienced treatment and follow up care in the United Kingdom
Key exclusion criteria (5 listed)
- Cancer survivors who were diagnosed with cancer below the age of 18 years
- Partners of cancer survivors who were diagnosed with cancer below the age of 18 years
- Cancer diagnosis was more than 10 years ago
- Cancer survivors/partners of survivors where the cancer treatment and follow up was not in the United Kingdom
- Previous completion of the survey
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionNo intervention | Other | Partners of People with Cancer, People with Cancer |
Primary outcome
Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care
Time frame: Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)
Sexual health discussion:19 examples of the sort of topics that may have been discussed in relation to sexual health
4 secondary outcomes
Number of participants with specific levels of impact on their sex lives by cancer and its treatments
Time frame: From each individual participants' cancer diagnosis/cancer treatment until the date that they completed the survey
Survey questionnaire to measure the nature and prevalence of care for sexual health that cancer survivors and their intimate partners self-report experiencing from the UK hospital cancer team.
Time frame: Participants can report care received from prior to their cancer treatment through to their follow-up care (last 10 years only)
Survey questionnaire to measure the nature and prevalence of the perceived barriers to and facilitators for care for sexual health as received by cancer survivors and their intimate partners when provided by the UK hospital cancer team.
Time frame: Participants can report their perceptions from diagnosis through to their follow-up care (last 10 years only)
Survey questionnaire to measure to what extent groups of cancer survivors and their intimate partners with differing characteristics receive differing care for their sexual health from the UK hospital cancer team.
Time frame: Participants diagnosed with cancer in the previous 10 years.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Oct 2023.
- Derived from this study: PubMed 40967121Sheppard S, Culliford D, Glen T, Lee S, Sheppard ZA, Porter S. Care for sexual health in oncology survey: a regression analysis of variables associated with the likelihood of people with cancer having a sexual health discussion with the hospital cancer team. Eur J Oncol Nurs. 2025 Oct;78:102977. doi: 10.1016/j.ejon.2025.102977. Epub 2025 Sep 1.
- Individual participant dataSharing planned: No. Participant information sheet stated that information would not be made publicly available via a data sharing repository. This approach was taken due to the sensitive nature of the topic and was anticipated to provide reassurance and potentially improve recruitment.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sam Porter, PhD, RN principal investigator
Bournemouth University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Bournemouth University at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of participants who had a sexual health discussion(s) with the hospital cancer team at any point during cancer care (time frame: Up to 10 years prior to completing survey (discussion(s) about sexual health could have occurred at any point during cancer care)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06074445, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2023.